Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to reach a market size of $1,180.7 million by 2024

According to a new report Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, published by KBV research, The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size is expected to reach $1,180.7 million by 2024, rising at a market growth of 30.4% CAGR during the forecast period.

The North America Market held the largest share in the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017. The Asia Pacific market is expected to witness a CAGR of 31.8% during the forecast period (2018 – 2024).

The Glaucoma in Conjunction with Cataract segment contributed the larger revenue share to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product in 2017, and would continue to be a dominant market till 2024 and is expected to grow at a CAGR of 29.8% during the forecast period. However, Stand Alone Glaucoma segment is expected to grow at CAGR of 31.0% over the forecast period.

The minimally invasive glaucoma surgery (MIGS) devices market on the basis of product is segmented into MIGS stents, MIGS shunts, and other. MIGS stents segment generated the highest revenue in 2017, and is anticipated to maintain the trend throughout the forecast period. The most widely accepted stents include iStent (Glaukos Coproration), CyPass MicroStent (Alcon/Novartis), and Hydrus Microstent (Irvine) being the prime factor to drive the market growth.

Full Report: https://kbvresearch.com/minimally-invasive-glaucoma-surgery-migs-devices-market

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

By Surgery

  • Glaucoma in Conjunction with Cataract
  • Stand Alone Glaucoma 

By Target

  • Suprachoroidal Space
  • Trabecular Meshwork
  • Others

By Product

  • MIGS Stents
  • MIGS Shunts
  • Other

By End User

  • Eye Hospitals
  • Ophthalmology Clinics
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Ellex Medical Lasers Ltd
  • Allergan Plc
  • Santen Pharmaceutical Co., Ltd.
  • Glaukos Corporation
  • Alcon Inc. (Novartis)
  • Lumenis
  • Ivantis, Inc.
  • iSTAR Medical
  • InnFocus Inc.
  • SOLX, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage 
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Related Reports:

North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2018-2024)

Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2018-2024)

Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2018-2024)

LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2018-2024)